<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: dystrophin protein</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>New design guidelines simplify development of targeted therapies for muscular dystrophy and other diseases</title>
   	 <description>The dystrophin protein offers critical support to muscle fibers. Mutations affecting dystrophin's expression cause the muscle-wasting disease muscular dystrophy. In Duchenne muscular dystrophy (DMD), these mutations take the form of small sequence changes that make much of the dystrophin gene (DMD) untranslatable, yielding nonfunctional protein or no protein at all.</description>
     <link>http://medicalxpress.com/news/2013-01-guidelines-therapies-muscular-dystrophy-diseases.html</link>
	 <category>Genetics</category>
	 <pubDate>Wed, 30 Jan 2013 07:00:01 EST</pubDate>
	 <guid isPermaLink="false">news278749682</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/genetherapye.jpg" width="90" height="90" />
</item>
<item>
     <title>Preclinical muscular dystrophy data shows promise</title>
   	 <description>Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder.</description>
     <link>http://medicalxpress.com/news/2012-11-preclinical-muscular-dystrophy.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 08 Nov 2012 10:06:22 EST</pubDate>
	 <guid isPermaLink="false">news271591571</guid>
	 
</item>
<item>
     <title>First targeted treatment success for Duchenne Muscular Dystrophy</title>
   	 <description>(Medical Xpress) -- A team led by scientists at UCL, funded by the Medical Research Council (MRC) and AVI BioPharma, have made an important breakthrough in the development of a treatment for Duchenne Muscular Dystrophy (DMD).</description>
     <link>http://medicalxpress.com/news/2011-07-treatment-success-duchenne-muscular-dystrophy.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 25 Jul 2011 09:25:35 EST</pubDate>
	 <guid isPermaLink="false">news230804709</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/firsttargete.jpg" width="90" height="90" />
</item>


</channel>
</rss>
